Plain-English translation of NCT05117723 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is building a large database of patients who have been diagnosed with intraductal papillary mucinous neoplasms (IPMNs)—a type of cyst that forms in the pancreas. By collecting medical records, imaging results, and surgical outcomes from up to 1,000 patients, researchers aim to better understand which IPMNs are likely to turn into pancreatic cancer and which ones can be safely watched over time.
Pancreatic cancer is deadly and often caught too late for treatment to work. Because IPMNs can sometimes become pancreatic cancer, doctors need better tools to predict which patients are at highest risk so they can catch cancer early or intervene before it develops. Right now, doctors follow international guidelines based mostly on expert opinion rather than solid research data.
You likely qualify if…
You likely don't qualify if…
Your participation would involve allowing researchers to access and review your medical records, imaging scans, and any surgical pathology reports related to your IPMN diagnosis. Some participants may already be scheduled for surveillance ultrasounds or surgery as part of their regular care, and the study would track those outcomes. There is no mention of new treatments or experimental medications—this is purely a data collection effort to build a research database.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Australia
Enrollment target
~1,000 participants
Started
August 2021
Primary completion
July 2031
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in April 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lynn Chong
St Vincent's Hospital Melbourne
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.